Global health advances in 2025 highlight new gene therapies, cancer treatment breakthroughs, HIV prevention, antimicrobial resistance initiatives, and expanded health coverage efforts.
1
United States and Uganda Sign $2.3 Billion Health Cooperation Framework
The US and Uganda have signed a five-year health cooperation agreement worth $2.3 billion, aiming to strengthen bilateral health initiatives and improve care delivery in Uganda.
2
Major Breakthroughs in Urologic Oncology in 2025
2025 saw advances in prostate and bladder cancer treatment, including FDA approvals for intravesical therapies and novel immunotherapies, alongside minimal residual disease-guided care transforming bladder cancer management.
3
WHO Highlights Universal Health Coverage Progress in Africa
The WHO Regional Director for Africa marked Universal Health Coverage Day emphasizing health as a human right and noting strong regional gains in service coverage for noncommunicable diseases and maternal-child health.
4
CRISPR Gene Therapy and AI Innovations Advance Biomedical Research
New personalized CRISPR base editing cures, off-the-shelf CAR7 T cells for leukemia, telomere-repair gene therapies, and AI tools predicting disease reversal marked key biomedical innovations in 2025.
5
EU Commission and WHO Enhance Antimicrobial Resistance Response
The EU and WHO signed an agreement to accelerate research and initiatives against antimicrobial resistance, including advancing bacteriophage therapy to target drug-resistant bacteria effectively.
6
FDA Approves New Treatments for Inflammatory Bowel Disease
The FDA approved several new drugs and indications in 2025 for ulcerative colitis and Crohn’s disease, expanding therapeutic options with emphasis on efficacy and patient safety.
7
WHO Confirms No Link Between Vaccines and Autism
The WHO Global Advisory Committee reaffirmed evidence from recent systematic reviews showing no causal relationship between vaccines and autism spectrum disorder.
8
Lenacapavir: Twice-Yearly Injection Nearly Eliminates HIV Infection in Trials
A novel capsid inhibitor, lenacapavir, administered biannually, showed nearly 100% efficacy in HIV pre-exposure prophylaxis trials, marking a significant advance in HIV prevention.
9
WHO Recommends Maintaining Controls on Coca Leaf After Rigorous Review
Following a comprehensive scientific review, WHO’s Expert Committee advised keeping existing international controls on coca leaf, reaffirming their validity after 75 years of regulation.
10
About 8 Million Babies Born Amid Conflicts and Climate Disasters in 2025
Reports indicate that around 8 million babies have been born this year in crisis conditions due to conflicts and climate disasters, often in inadequate healthcare environments.